EBT
ATRS

Enterprise Bank & Trust’s Antares Pharma, Inc. ATRS Stock Holding History

Enterprise Bank & Trust’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,000
Closed -$45K – 110
2019
Q1 		$45K Buy
+15,000
New +$48.6K 0.02% 105

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Enterprise Bank & Trust's ATRS Position: Q2 2019 in Review

Enterprise Bank & Trust sold out of Antares Pharma, Inc. (ATRS) in Q2 2019, closing a stake of 15,000 shares — an estimated $45K sold.

Enterprise Bank & Trust first reported a position in ATRS in Q1 2019 and held it in 1 quarter. The position peaked at $45K in Q1 2019. 127 funds tracked by Wall St. Rank hold ATRS as of Q2 2019.

  • Enterprise Bank & Trust reported no remaining Antares Pharma, Inc. position as of Q2 2019 after selling out during the quarter.
  • Enterprise Bank & Trust sold 15,000 Antares Pharma, Inc. shares in Q2 2019, an estimated $45K.
  • Enterprise Bank & Trust first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 1 quarter.
  • Enterprise Bank & Trust's Antares Pharma, Inc. position peaked at $45K in Q1 2019.
  • 127 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2019.

Based on Enterprise Bank & Trust's 13F filing for Q2 2019, filed 12 Jul 2019.